Introduction
The choice of drugs for seizure management is predicated by the type of seizure and the pharmacological side effects. Among the side effects considered, cognitive dysfunction is often cited. Over the past decade, there has been a growing trend to switch patients to antiepileptics with fewer cognitive side effects. In actual practice, this often requires switching patients from phenytoin (PHT) to carbamazepine (CBZ), as these popular antiepileptics are judged to be equally efficacious in the management of generalized and partial epilepsy (1) .
Several studies over the past decade have evaluated the cognitive effects of phenytoin and carbamazepine (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Cognitive function, as defined by M.R. Trimble, is defined as the &dquo;ability of a person to use information about and from his or her environment in an adaptive way&dquo; (13) . The bulk of the data suggests that carbamazepine causes less cognitive dysfunction than phenytoin-when using neuropsychological tests as the standard for comparison (2, 5, 7, 13, 15, 16 ). Andrews compared patients on CBZ to PHT and found that the CBZ group performed better on memory tasks involving short-term memory scanning, word list learning, and memory for prose (2 Table 4 .) Again, no significant differences 
